跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Glaxosmithkline (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 22, 2022
Approval ID
b12fe6ea27ba23ba
Company
Glaxosmithkline (Ireland) Limited
Type
Standard
Approval Details
Approval Id
b12fe6ea27ba23ba
Drug Cima Aemps Name
ZINNAT 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
15-061-88-C-CIP
Holder Company Name
Glaxosmithkline (Ireland) Limited
Marketing Company Name
Elam Pharma Labs S.L.
Holder Company Detail Path
/organization/glaxosmithkline-ireland-limited
Authorization Date
2022-09-22
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
500 mg cefuroxima axetilo
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Glaxosmithkline (Ireland) Limited
Company Detail Path
/organization/glaxosmithkline-ireland-limited
Company Information
Pharmaceutical Company Name
GLAXOSMITHKLINE (IRELAND) LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
12 RIVERWALK
Active Ingredients
CEFUROXIMA AXETILO
601,44 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 22, 2022
Approval ID
b12fe6ea27ba23ba
Type
Standard
Back to CIMA-AEMPS Approvals
